Patents by Inventor Jia Jiang

Jia Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050288483
    Abstract: The invention relates to compounds of formula I: x+y+z=1 and x=0 to 1, y=0 to 1, z=0 to 1 and R is CH3 or CF3 and R1 and R2 each represent H or a functional group. These compounds show promise in films and as optical waveguide materials as well as bimodal interference coupler and arrayed waveguide grating demultiplexer materials.
    Type: Application
    Filed: May 19, 2005
    Publication date: December 29, 2005
    Inventors: Jianfu Ding, Michael Day, Tyler Norsten, Yinghua Qi, Claire Callender, Jia Jiang
  • Publication number: 20040192608
    Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises an analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
    Type: Application
    Filed: May 11, 2004
    Publication date: September 30, 2004
    Applicant: Metabolic Pharmaceuticals Ltd.
    Inventors: Frank Man-Woon Ng, Woei-Jia Jiang
  • Patent number: 6737407
    Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises an analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: May 18, 2004
    Assignee: Metabolic Pharmaceuticals, Ltd.
    Inventors: Frank Man-Woon Ng, Woel-Jia Jiang
  • Publication number: 20020142965
    Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises the carboxyl-terminal sequence of a growth hormone, particularly the carboxyl-terminal sequence of human growth hormone containing amine acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
    Type: Application
    Filed: December 31, 2001
    Publication date: October 3, 2002
    Applicant: Metabolic Pharmaceuticals, Ltd.
    Inventors: Frank Man-Woon Ng, Siria Helens Anna Natera, Woei-Jia Jiang
  • Patent number: 6335319
    Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises the carboxyl-terminal sequence of a growth hormone, particularly the carboxyl-terminal sequence of human growth hormone containing amine acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
    Type: Grant
    Filed: February 8, 1999
    Date of Patent: January 1, 2002
    Assignee: Metabolic Pharmaceuticals, Inc.
    Inventors: Frank Man-Woon Ng, Siria Helen Anna Natera, Woei-Jia Jiang
  • Patent number: 5869452
    Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises the carboxyl-terminal sequence of a growth hormone, particularly the carboxyl-terminal sequence of human growth hormone containing amine acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
    Type: Grant
    Filed: November 15, 1994
    Date of Patent: February 9, 1999
    Assignee: Monash University
    Inventors: Frank Man-Woon Ng, Siria Helen-Anna Natera, Woei-Jia Jiang